As of November 6, 2026, Niki BioSolutions, Inc. is a publicly traded company (Nasdaq: NIKI). Kira Sheinerman, a director and 10% owner, reports holding 51.56%, a majority of its shares. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13D, July 24, 2026).
Is this your company?
About to sign with, pay or invest in Niki BioSolutions, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Niki BioSolutions, Inc. a real, registered company?
- Niki BioSolutions, Inc. files with the SEC under CIK 1734005 (its SEC filings).
- Its shares are listed under the ticker NIKI on Nasdaq (SEC company record).
- Incorporated in E9; business address in Princeton, New Jersey, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Niki BioSolutions, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Thomas Freeburg, Chief Financial Officer (Form 8-K filed 2026-10-13). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Kira S. Sheinerman (filed 2026-07-24).
Who are Niki BioSolutions, Inc.'s owners and officers?
Niki BioSolutions, Inc.: business address in Princeton, New Jersey; industry Measuring & Controlling Devices, NEC (Form D, 2026-10-13).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D, 2026-07-24 | Kira S. Sheinerman | 51.56% |
Want the whole picture on Niki BioSolutions, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Niki BioSolutions, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Niki BioSolutions, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-10-13 | Thomas Freeburg | Chief Financial Officer | appointed |
Which insiders own Niki BioSolutions, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 1,515,293 shares (Form 3, 2026-07-24).
- , a director: 6,024 shares (Form 3, 2026-07-24).
- , a director: 1,832 shares (Form 3, 2026-08-13).
- , a director: 1,062 shares (Form 3, 2026-08-13).
Shares only: the company's cover page does not give one share count for a single class, so no percentage is worked out.
How much has Niki BioSolutions, Inc. raised?
Latest IPO step: Niki BioSolutions, Inc. withdrew its IPO registration (RW, 2026-08-28).
IPO filings: RW, 2026-08-28, F-1, 2025-11-17.
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-07-20).
Keep reading
More on Niki BioSolutions, Inc. and the records around it.
Niki BioSolutions, Inc. elsewhere on the record
- Leadership changes Sep 2026
- 5%+ stake filings Jul 2026
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/niki-biosolutions